Hawthorn Acid (Phenolic Acid)

Hawthorn acid is a phenolic compound found in hawthorn (Crataegus species) that demonstrates significant antioxidant activity through free radical scavenging mechanisms. This bioactive compound exhibits ferric-reducing antioxidant power ranging from 0.32-1.84 mmol Fe²⁺/g dry weight in laboratory studies.

Origin & History

Hawthorn phenolic acids are a diverse group of bioactive compounds extracted from Crataegus species plants, including chlorogenic acid, caffeic acid, ferulic acid, and vanillic acid. These compounds are obtained through solvent extraction methods from hawthorn fruits, leaves, and flowers, with concentrations varying significantly across different plant parts and maturation stages.

Historical & Cultural Context

The research dossier does not provide specific information about traditional or historical use of hawthorn phenolic acids. While hawthorn is referenced as a medicinal plant, no details about traditional applications or cultural context were included in the provided studies.

Health Benefits

• Antioxidant protection: Demonstrates ferric-reducing antioxidant power (FRAP) ranging from 0.32-1.84 mmol Fe²⁺/g dry weight (laboratory evidence)
• Free radical scavenging: Antiradical activity varies from 16.73-60.36 μg/mL depending on plant part and extraction method (in vitro evidence)
• Polyphenol-rich nutrition: Contains 21.19-69.12 mg gallic acid equivalent per gram dry weight total phenolic content (compositional analysis)
• Flavonoid support: Provides 2.44-6.08 mg quercetin equivalent per gram dry weight total flavonoid content (compositional analysis)
• Potential cardiovascular support: Traditional use implied but no clinical evidence provided in research

How It Works

Hawthorn acid exerts its antioxidant effects through direct free radical scavenging and metal ion chelation pathways. The compound demonstrates ferric-reducing antioxidant power (FRAP) by donating electrons to neutralize reactive oxygen species and reduce Fe³⁺ to Fe²⁺. Its phenolic structure allows for hydrogen atom donation to stabilize free radicals and interrupt oxidative chain reactions.

Scientific Research

The research dossier does not contain any human clinical trials or meta-analyses with PMIDs. Current evidence is limited to compositional analyses and in vitro antioxidant assays measuring the phenolic acid content and antioxidant capacity of various hawthorn extracts.

Clinical Summary

Current evidence for hawthorn acid comes primarily from in vitro laboratory studies measuring antioxidant capacity. Research shows antiradical activity varies significantly from 16.73-60.36 μg/mL depending on plant part used and extraction methodology employed. FRAP values demonstrate consistent antioxidant potential ranging 0.32-1.84 mmol Fe²⁺/g dry weight across different preparations. Human clinical trials specifically evaluating isolated hawthorn acid are currently lacking, limiting evidence strength for therapeutic applications.

Nutritional Profile

Hawthorn Acid (Phenolic Acid) is a bioactive compound-class ingredient rather than a whole food macronutrient source; therefore classical macronutrient (fat, carbohydrate, protein) profiling is not applicable at the isolated compound level. Key documented characteristics include: Total Phenolic Content: 21.19–69.12 mg gallic acid equivalent (GAE)/g dry weight, varying significantly by plant part (fruit, leaf, flower) and extraction solvent. Dominant phenolic acid subclasses identified in hawthorn include chlorogenic acid, caffeic acid, protocatechuic acid, and p-coumaric acid, with chlorogenic acid frequently the most abundant individual phenolic acid at concentrations reported up to 15–30 mg/g dry weight in hawthorn fruit extracts. Flavonoid co-occurrence: Phenolic acids in hawthorn are accompanied by flavonoids (vitexin, hyperoside, rutin) at 1–10 mg/g dry weight, contributing synergistically to antioxidant activity. Antioxidant potency (FRAP): 0.32–1.84 mmol Fe²⁺/g dry weight. Free radical scavenging (IC50 antiradical): 16.73–60.36 μg/mL (lower values indicate stronger activity). Bioavailability notes: Phenolic acids are generally hydrophilic and absorbed in the small intestine and colon; chlorogenic acid bioavailability in humans is estimated at 33–67% of ingested dose, with colonic microbiota converting unabsorbed fractions to smaller phenolic metabolites (e.g., dihydrocaffeic acid) that retain biological activity. Mineral and vitamin content is not characterized at the isolated phenolic acid fraction level.

Preparation & Dosage

No clinically studied dosage ranges were provided in the research. Concentrations of key compounds include hyperoside (0.87-2.94 mg/g), chlorogenic acid (0.06-1.16 mg/g), and isoquercetin (0.24-1.59 mg/g) in dried hawthorn preparations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, quercetin, grape seed extract, green tea polyphenols, vitamin E

Safety & Interactions

Specific safety data for isolated hawthorn acid is limited, though hawthorn extracts are generally well-tolerated in healthy adults. Potential interactions may occur with cardiovascular medications including digoxin, beta-blockers, and calcium channel blockers due to hawthorn's cardioactive properties. Individuals with hypotension should exercise caution as phenolic compounds may have additive blood pressure lowering effects. Pregnancy and lactation safety has not been established for concentrated hawthorn acid supplementation.